Press Releases

Acquisition Expands Schrödinger’s Leadership in Structure-Based Drug Discovery NEW YORK --(BUSINESS WIRE)--Jan. 18, 2022-- Schrödinger , Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the acquisition of

NEW YORK --(BUSINESS WIRE)--Jan. 5, 2022-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the H.C. Wainwright BioConnect Conference .
Displaying 31 - 32 of 32
Back To Top